首页> 外文期刊>Journal of Translational Medicine >Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
【24h】

Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features

机译:Msx-1的表达在双膦酸盐相关的骨坏死相关的颌骨组织病理病理学方面受颌骨发育生物学相关的独特特征的抑制

获取原文
           

摘要

Background Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab (anti-RANKL antibody)-related ONJ to jaws. Msx-1 is exclusively expressed in craniofacial structures and pivotal to cranial neural crest (CNC)-derived periodontal tissue remodeling. We hypothesised that Msx-1 expression might be impaired in bisphosphonate-related ONJ. The study aim was to elucidate Msx-1 and RANKL-associated signal transduction (BMP-2/4, RANKL) in ONJ-altered and healthy periodontal tissue. Methods Twenty ONJ and twenty non-BP exposed periodontal samples were processed for RT-PCR and immunohistochemistry. An automated staining-based alkaline phosphatase-anti-alkaline phosphatase method was used to measure the stained cells:total cell-number ratio (labelling index, Bonferroni adjustment). Real-time RT-PCR was performed on ONJ-affected and healthy jaw periodontal samples (n = 20 each) to quantitatively compare Msx-1, BMP-2, RANKL, and GAPDH mRNA levels. Results Semi-quantitative assessment of the ratio of stained cells showed decreased Msx-1 and RANKL and increased BMP-2/4 (all p Conclusions These results explain the sclerotic and osteopetrotic changes of periodontal tissue following BP application and substantiate clinical findings of BP-related impaired remodeling specific to periodontal tissue. RANKL suppression substantiated the clinical finding of impaired bone remodelling in BP- and aRANKL-induced ONJ-affected bone structures. Msx-1 suppression in ONJ-adjacent periodontal tissue suggested a bisphosphonate-related impairment in cellular differentiation that occurred exclusively jaw remodelling. Further research on developmental biology-related unique features of jaw bone structures will help to elucidate pathologies restricted to maxillofacial tissue.
机译:背景骨破坏性疾病的治疗包括双膦酸盐和抗破骨细胞分化剂RANKL(aRANKL)的抗体;但是,颌骨坏死(ONJ)是常见的副作用。当前的模型无法解释双膦酸酯(BP)相关和地诺单抗(anti-RANKL抗体)相关的ONJ对颌骨的限制。 Msx-1仅在颅面结构中表达,对颅神经neural(CNC)衍生的牙周组织重塑至关重要。我们假设在双膦酸酯相关的ONJ中Msx-1表达可能受损。该研究的目的是阐明ONJ改变的健康牙周组织中的Msx-1和RANKL相关信号转导(BMP-2 / 4,RANKL)。方法对20例ONJ和20例非BP暴露的牙周样品进行RT-PCR和免疫组化分析。基于自动染色的碱性磷酸酶-抗碱性磷酸酶方法用于测量染色的细胞:总细胞数比(标记指数,Bonferroni调节)。对受ONJ影响的健康颌骨牙周样品(每个n = 20)进行实时RT-PCR,以定量比较Msx-1,BMP-2,RANKL和GAPDH mRNA水平。结果染色细胞比例的半定量评估显示Msx-1和RANKL降低,而BMP-2 / 4升高(所有p结论)这些结果解释了BP施用后牙周组织的硬化和骨质改变,并证实了BP-相关的牙周组织重塑受损。RANKL抑制证实了BP和aRANKL诱导的ONJ影响的骨结构中骨重塑受损的临床发现。ONJ邻近牙周组织中的Msx-1抑制表明双膦酸盐相关的细胞分化障碍颚骨结构发育生物学相关的独特特征的进一步研究将有助于阐明仅限于颌面组织的病理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号